Neal Shore: Efficacy and Safety of Treatments for Metastatic Castration-Sensitive Prostate Cancer
Neal Shore/LinkedIn

Neal Shore: Efficacy and Safety of Treatments for Metastatic Castration-Sensitive Prostate Cancer

Neal Shore, Director of START GU Oncology Center of Excellence at The START Center for Cancer Research, shared a post on LinkedIn:

“Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data.”

Authors: Neal Shore, Alicia Morgans, Noman Paracha, Elaine Gallagher, Howard Thom, David Aceituno, Philip Orishaba, Stephen Stefani, Quoc-Dien Trinh, Christopher Wallis, Keith Abrams, Martin Boegemann

Read the Full Article.

Neal Shore: Efficacy and Safety of Treatments for Metastatic Castration-Sensitive Prostate Cancer

More posts about Prostate Cancer.